This site is intended for healthcare professionals
Login
Register
Medical Education
Specialty
Drugs
News
Congresses
Search
Menu
Medical Education
Specialty
Drugs
News
Congresses
Home
/
Discontinued Drugs
/
New drug name(14)(16)(25)
Discontinued drug
New drug name(14)(16)(25)
Read time:
1 mins
Last updated:
21st Sep 2020
Share
Alternative approved drugs and related content
News
Fasenra (benralizumab) is approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis .- AstraZeneca
1 mins
News
Alnylam submits regulatory application to the European Medicines Agency for vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy
1 mins
Drug news
Oral Fabhalta (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial.- Novartis
3 mins
Industry news
Lyell Immunopharma to acquire ImmPACT Bio USA and with it IMPT 314
1 mins
Drug news
Pivotal VALIANT results presented at Kidney Week highlight strength of pegcetacoplan treatment effect in patients with C3G / Primary IC-MPGN- Sobi + Apellis
2 mins
Drug news
FDA approves Orlynvah (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections,- Iterum Therapeutics
1 mins
Industry news
AbbVie and Gedeon Richter tocollaborate on for the discovery and development of novel targets for neuropsychiatric conditions
1 mins
News
AbbVie and Gedeon Richter to collaborate on the discovery and development of novel targets for neuropsychiatric conditions
1 mins
Drug news
New SPECTREM study findings reveal Tremfya (guselkumab) effectively clears overlooked and undertreated plaque psoriasis- Johnson & Johnson
4 mins
Drug news
Dupixent late-breaking positive phase III data in chronic spontaneous urticaria to be presented at ACAAI- Sanofi
1 mins
Drug news
Darzalex (daratumumab-SC) based quadruplet regimen is approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible
1 mins
Industry news
Merck Inc., acquires Modifi Biosciences Inc.
1 mins
Drug news
FDA approval for Affera mapping and ablation system with Sphere-9 catheter for treatment of persistent atrial fibrillation
1 mins
Industry news
Bayer to licence a heart disease program from Dewpoint Therapeutics to treat dilated cardiomyopathy
1 mins
Drug news
TEAM-HF trial to measure pulmonary pressures using CardioMEMS HF System
3 mins
Drug news
Rigel Pharmaceuticals issues Dear Health Care Provider letter relating to Gavreto (pralsetinib)
1 mins
Drug news
FDA approves Keytruda (pembrolizumab) for endometrial carcinoma and FIGO 2014 Stage III-IVA cervical cancer
1 mins
Drug news
FDA approval for Abrysvo (respiratory syncytial virus vaccine), for prevention of LRTD caused by RSV in individuals 18 to 59 years
1 mins
Drug news
Successful outcome of interaction with FDA to deterime pathway for ST 920 (isaralgagene civaparvovec) for Fabry disease
1 mins
Drug news
FDA’s decision on the sNDA of sotorasib and panitumumab in KRAS G12C-mutated chemorefractory metastatic CRC has been delayed
1 mins
Top